Genetics, Immunophenotyping Help Drive CLL Treatment Selection, but More Knowledge Needed

Genetics, Immunophenotyping Help Drive CLL Treatment Selection, but More Knowledge Needed

An education session at the 2022 European Hematology Association Congress featured updates on using genetic and immune characteristics to select the optimal treatment pathway in chronic lymphocytic leukemia (CLL). An education session at the 2022 European Hematology Association (EHA) Congress featured speakers delivering updates on the status of using genetic and immune characteristics to select … Read more